Image

Global Cardiac Mapping Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Cardiac Mapping Market, By Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), System (Contact Cardiac Mapping Systems, Non-contact Cardiac Mapping Systems) – Industry Trends and Forecast to 2029.

Cardiac Mapping Market

Cardiac Mapping Market Analysis and Size

Cardiac mapping is used to distinguish between the roles played by normal and abnormal heart rates in order to provide accurate diagnostic treatment and to identify arrhythmia in order to provide accurate treatment. The market is anticipated to grow more quickly throughout the forecast period.

Data Bridge Market Research analyses that the cardiac mapping market which was USD 860.89 million in 2021, would rocket up to USD 1886.04 million by 2029, and is expected to undergo a CAGR of 10.3% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cardiac Mapping Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), System (Contact Cardiac Mapping Systems, Non-contact Cardiac Mapping Systems)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Biosense Webster (U.S.), Abbott (U.S.),  Boston Scientific Corporation (U.S.), Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions (Switzerland), Acutus Medical Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Lepu Medical  Technology Co. Ltd. (China), BIOTRONIK (Germany), AngioDynamics (U.S.), BioSig Technologies (U.S.), APN Health (U.S.), CoreMap (U.S.), Kardium (Canada), Catheter Precision (U.S.), and Epmap-System  (Germany)

Market Opportunities

  • Rise in demand for accurate cardiac disease diagnosis
  • Rise in accessibility of interventional cardiologists

Market Definition

Cardia mapping is a general word that refers to a variety of mapping techniques, including body surface mapping, endocardial mapping, and epicardial mapping, among others. Identification of the temporal and unique distribution of the myocardial electric potential during a certain heart rhythm is known as cardiac mapping. In particular, mapping refers to understanding the cardiac rhythm or clarifying the workings of the cardiovascular system.

Cardiac Mapping Market Dynamics

Drivers

  • Increase in prevalence of cardiac conditions

The prevalence of conditions like an atrial flutter, which is characterized by abnormally rapid heartbeats also known as supraventricular tachycardia, is increasing and boosting the market for cardiac mapping. Due to the prevalence of atrial flutter, cardiac mapping is primarily performed using radiofrequency catheters, driving the market's expansion.

  • Growing population of geriatrics

The substantial prevalence of the cardiac mapping market throughout the forecast period of 2022 to 2029 has been greatly aided by the growing population of geriatrics, the elderly, and people who have chronic heart conditions. And also the technology improvements are helping the cardiac mapping market expand in new economies.

  • Technological Innovations

Growing technologies will probably accelerate market expansion during the anticipated term. As new technologies enter the market, existing therapy options are being replaced with ones that provide faster results, better precision and efficacy, and cover arrhythmia. With the aid of non-fluoroscopy catheter navigation, the most recent technologies are introduced with little exposure to ionising radiation (fluoroscopy). In order to provide patients with improved treatment alternatives that are financially feasible, these reasons are likely to encourage hospital doctors to adopt new technologies. Therefore, these elements are likely to boost the market.

Opportunities

In the forecast period, it is anticipated that the adoption of a variety of cutting-edge diagnostic technologies by medical device companies, the rise in demand for accurate cardiac disease diagnosis, and the accessibility of interventional cardiologists with the necessary training in developing economies will all contribute to the growth of the market for cardiac mapping systems.

Restraints/Challenges

During the period of growth, the cardiac mapping market is exposed to some restraining factors which can hinder the market expansion, such as undefined healthcare transformation and dearth of trained professionals to handle the electrophysiology.

This cardiac mapping market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiac mapping market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Cardiac Mapping Market

The market for cardiac mapping is expanding as a result of the COVID-19 disease pandemic. According to a research project titled "Cardiac Involvement of COVID-19: A Comprehensive Review" published in January 2021, COVID-19 can significantly affect patients' cardiovascular systems. Diabetes, hypertension, and cardiovascular disease all significantly increase the risk of dying from COVID-19. Therefore, patients with CVDs must take all necessary precautions to avoid COVID-19, which may require cardiac mapping.

Recent Development

  • In January 2022, Affera, Inc., a privately held medical technology business in the Boston region, will be acquired by Medtronic plc, a leader in worldwide healthcare technology. The cardiac mapping and navigation systems are created and produced by Affera.
  • In January 2022,  Abbott received FDA approval for its EnSite X EP with EnSite Omnipolar technology. EnSite X EP creates detailed three-dimensional maps of the heart to help medical professionals locate and treat the regions of the organ where abnormal rhythms arise.

Global Cardiac Mapping Market Scope

The cardiac mapping market is segmented on the basis of indication, system. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

  • Atrial Fibrillation
  • Atrial Flutter
  • AVNRT

 System

  • Contact Cardiac Mapping Systems
  • Non-contact Cardiac Mapping Systems

Cardiac Mapping Market Regional Analysis/Insights

The cardiac mapping market is analysed and market size insights and trends are provided by country, indication, system as referenced above.

The countries covered in the cardiac mapping market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cardiac mapping market due to the high prevalence of government organizations aiding in the research funds.

 Asia-Pacific (APAC) is emerging due to successive ratio of geriatric population, lucrative compensation polices for the cardiac mapping services.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Cardiac Mapping Market Share Analysis

The cardiac mapping market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cardiac mapping market.

Some of the major players operating in the cardiac mapping market are:

  • Biosense Webster (U.S.)
  • Abbott (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Medtronic (Ireland)
  • MicroPort Scientific Corporation (China)
  • EP Solutions (Switzerland)
  • Acutus Medical Inc. (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • Lepu Medical Technology Co. Ltd. (China)
  • BIOTRONIK (Germany)
  • AngioDynamics (U.S.)
  • BioSig Technologies (U.S.)
  • APN Health (U.S.)
  • CoreMap (U.S.)
  • Kardium (Canada)
  • Catheter Precision (U.S.)
  • Epmap-System  (Germany)


SKU-
Why Choose Us


Frequently Asked Questions

The cardiac mapping market value is expected USD 1886.04 million by 2029.
The cardiac mapping market is projected to grow at a CAGR of 10.3% during the forecast period of 2022-2029.
The major players operating in the Cardiac Mapping Market are Biosense Webster (U.S.), Abbott (U.S.), Boston Scientific Corporation (U.S.), Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions (Switzerland), Acutus Medical Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Lepu Medical Technology Co. Ltd. (China), BIOTRONIK (Germany), AngioDynamics (U.S.), BioSig Technologies (U.S.), APN Health (U.S.), CoreMap (U.S.), Kardium (Canada), Catheter Precision (U.S.), and Epmap-System (Germany).
The major countries covered in the Cardiac Mapping Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.